Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
NCT07400718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-02-12
Summary
This clinical study, titled "Head-to-Head Comparison Study between Different FDA Registered Allergy Skin Test Applicators," aims to compare the reliability and clinical performance of three skin prick test (SPT) devices: Allertest™ Multiple Skin Test Applicator, Lincoln Multi-Test II, and Greer Skintestor OMNI Applicator. The primary objective is to evaluate the consistency and accuracy of these devices in allergy testing.
Conditions
- Allergy
- Hypersensitivity, Immediate
- Ig-E Mediated Food
Interventions
- DEVICE
-
AllerTest-10 Multi-Head Skin Test Device
FDA-cleared 10-head percutaneous skin test applicator manufactured by MedScience Research Group, Inc., distributed by ALK Abello, Inc. The device consists of 10 individual test heads arranged in a linear array, each with a standardized needle length designed to penetrate the epidermis without drawing blood. Applied with standardized pressure for simultaneous delivery of 10 test substances (histamine and glycerin controls in this study). Single-use, disposable device.
- DEVICE
-
Skintestor OMNI Multi-Head Skin Test Device
FDA-cleared 10-head percutaneous skin test applicator manufactured by Greer Laboratories, Inc. The device consists of 10 individual test heads arranged in a linear array for simultaneous application of multiple allergens and controls. Applied with standardized pressure for delivery of histamine and glycerin controls in this study. Single-use, disposable device.
- DEVICE
-
Multi-Test II Multi-Head Skin Test Device
FDA-cleared 8-head percutaneous skin test applicator manufactured by Lincoln Diagnostics, Inc. The device consists of 8 individual test heads arranged in a linear array for simultaneous application of multiple allergens and controls. Applied with standardized pressure for delivery of histamine and glycerin controls in this study. Single-use, disposable device.
- DEVICE
-
AllerTest-8 Multi-Head Skin Test Device
FDA-cleared 8-head percutaneous skin test applicator manufactured by MedScience Research Group, Inc., distributed by ALK Abello, Inc. The device consists of 8 individual test heads arranged in a linear array, each with a standardized needle length designed to penetrate the epidermis without drawing blood. Applied with standardized pressure for simultaneous delivery of 8 test substances (histamine and glycerin controls in this study). Single-use, disposable device.
Sponsors & Collaborators
-
ALK-Abelló A/S
collaborator INDUSTRY -
QHSLab, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-11-12
- Primary Completion
- 2025-11-30
- Completion
- 2026-01-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers
NCT03301870 ·Status: COMPLETED ·Phase: PHASE1
-
Microassay and Allergy Skin Prick Test Correlation Study
NCT03514303 ·Status: UNKNOWN
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
NCT01063985 ·Status: COMPLETED
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA
-
Skin Characteristics of Parents of Food Allergic Pediatric Patients
NCT04198753 ·Status: SUSPENDED
-
DermAI to Evaluate Human Factor of Testing
NCT06387472 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
NCT01518348 ·Status: WITHDRAWN ·Phase: PHASE3
-
Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.
NCT00665483 ·Status: COMPLETED ·Phase: PHASE4
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient Experience and Quality of Patch Testing on the Legs vs Back
NCT06191627 ·Status: RECRUITING ·Phase: NA
-
Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
NCT05918354 ·Status: COMPLETED
-
Diagnosing Drug Allergy: the T is the Key
NCT06409884 ·Status: RECRUITING ·Phase: NA
-
Sensitization Study of ATx201 in Healthy Volunteers
NCT03375957 ·Status: COMPLETED ·Phase: PHASE1
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
NCT00640614 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Simple Blood Lancet(Vitrex®)With DuoTip as Skin Prick Test Devices Among Mite-sensitized Subjects
NCT01197274 ·Status: COMPLETED
-
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
NCT03835767 ·Status: RECRUITING ·Phase: PHASE2
-
Atopy Patch Test in Normal Population : Pilot Study
NCT01156038 ·Status: COMPLETED ·Phase: PHASE1
-
Repeatability and Reproducibility of Skin Test Endpoint Titration
NCT03489694 ·Status: COMPLETED
-
Comparison of Skin Prick Testing and Intradermal Skin Test Result of Local and Imported Insect Allergen Extracts
NCT03645291 ·Status: COMPLETED ·Phase: NA
-
Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw Food
NCT01508299 ·Status: COMPLETED ·Phase: NA
-
Monitoring Of Scratch Via Accelerometry In Children
NCT03873220 ·Status: COMPLETED
-
Cumulative Irritation Potential of 828 Ointment
NCT00767455 ·Status: COMPLETED ·Phase: PHASE1
-
Accuracy Of Skin Prick Test Using In-house Wheat Extract For The Diagnosis Of IgE-mediated Wheat Allergy: A Pilot Study
NCT01070368 ·Status: COMPLETED ·Phase: NA